Walleye Trading LLC Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Call Options

30 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $4.71 Million - $5.53 Million	4,600 Added 418.18%	5,700 $5.99 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $176,640 - $214,238	-200 Reduced 15.38%	1,100 $1.16 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $10.5 Million - $11.5 Million	-11,600 Reduced 89.92%	1,300 $1.25 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $232,553 - $264,510	-300 Reduced 2.27%	12,900 $11.3 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $3.6 Million - $4.39 Million	5,200 Added 65.0%	13,200 $10.9 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $12.5 Million - $14.9 Million	-17,900 Reduced 69.11%	8,000 $5.75 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $9.87 Million - $12 Million	14,500 Added 127.19%	25,900 $21.3 Million
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $8.05 Million - $8.74 Million	-11,400 Reduced 50.0%	11,400 $8.22 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $9.81 Million - $12.4 Million	17,100 Added 300.0%	22,800 $15.7 Million
Q2 2022 Aug 08, 2022	SELL	$548.35 - $738.84 $822,525 - $1.11 Million	-1,500 Reduced 20.83%	5,700 $3.37 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $2.62 Million - $3.07 Million	-4,400 Reduced 37.93%	7,200 $5.03 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $1.36 Million - $1.68 Million	2,500 Added 27.47%	11,600 $7.33 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $4.76 Million - $5.65 Million	8,300 Added 1037.5%	9,100 $5.51 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $803,760 - $949,517	-1,700 Reduced 68.0%	800 $447,000
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $2.01 Million - $2.47 Million	-4,500 Reduced 64.29%	2,500 $1.18 Million
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $526,130 - $668,778	-1,100 Reduced 13.58%	7,000 $3.38 Million
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $817,125 - $987,315	1,500 Added 22.73%	8,100 $4.53 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $2.22 Million - $2.9 Million	4,500 Added 214.29%	6,600 $4.12 Million
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $806,832 - $1.19 Million	-2,400 Reduced 53.33%	2,100 $1.03 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $2.38 Million - $3.28 Million	-8,700 Reduced 65.91%	4,500 $1.69 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $54,691 - $63,678	200 Added 1.54%	13,200 $3.66 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $1.08 Million - $1.49 Million	3,600 Added 38.3%	13,000 $4.07 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $1.49 Million - $1.76 Million	4,000 Added 74.07%	9,400 $3.86 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $369,402 - $443,344	-1,100 Reduced 16.92%	5,400 $2.02 Million
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $702,280 - $817,020	2,000 Added 44.44%	6,500 $2.63 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $256,140 - $310,491	900 Added 25.0%	4,500 $1.55 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $1.58 Million - $1.97 Million	-5,000 Reduced 58.14%	3,600 $1.24 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $1.65 Million - $2.16 Million	4,600 Added 115.0%	8,600 $3.24 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $1.16 Million - $1.36 Million	2,700 Added 207.69%	4,000 $1.79 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,300	1,300 $638,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account